Andrew Tsai
Analyst at Jefferies
Replay available
Vistagen Therapeutics, Inc. (VTGN) Q1 2022 Earnings Call
Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Q1 2022 earnings conference call, held 2021-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jerry Dodson
Chief Financial Officer
Sean Singh
Chief Executive Officer
Dr. Mark Smith
Chief Medical Officer
Mark Flather
Vice President of Investor Relations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vistagen Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:05.292 Greetings and welcome to the VistaGen Therapeutic first quarter 2022 00:00:05.292 -- 00:00:10.695 results conference call. During the presentation, all participants will be in a listen-only 00:00:10.695 -- 00:00:15.518 mode. Afterwards, we will conduct a question and answer session. 00:00:15.518 -- 00:00:21.281 At that time, if you have a question, please press the 1 followed by the 4 on your telephone. 00:00:21.281 -- 00:00:25.153 If at any time during the conference you need to reach an operator, please press star 00:00:25.153 -- 00:00:26.954 0. 00:00:26.954 -- 00:00:32.017 As a reminder, this conference is being recorded today, Thursday, August 00:00:32.017 -- 00:00:33.598 12th, 2021. 00:00:33.598 -- 00:00:35.739 I would now like to turn the conference over to Mr. 00:00:35.739 -- 00:00:39.061 Mark Flather, Vice President of Investor Relations. 00:00:39.061 -- 00:00:40.922 Please go ahead, sir. 00:00:40.922 -- 00:00:45.625 Thank you, Nadir. Hello and welcome to the Vistagen's conference call covering its fiscal 00:00:45.625 -- 00:00:49.307 year 2022 first quarter financial results and corporate update. 00:00:49.307 -- 00:00:52.935 I am Mark Flather, Vice President of Investor Relations at Vistagen. 00:00:52.935 -- 00:00:56.518 Thank you for joining us today for this business update, and welcome to our shareholders, 00:00:56.518 -- 00:00:59.440 analysts, and anyone taking an interest in Vistagen. 00:00:59.440 -- 00:01:04.203 Joining me today are Sean Singh, our Chief Executive Officer, Jerry Dodson, our Chief 00:01:04.203 -- 00:01:08.506 Financial Officer, and Dr. Mark Smith, our Chief Medical Officer. 00:01:08.506 -- 00:01:11.848 The format for this call consists of prepared remarks from management, followed by an 00:01:11.848 --...